New drug for asthma, Singulair (montelukast)

March 1998

You'll see a new drug for asthma, Singulair (montelukast). Merck is launching it now in the U.S....later in Canada.

Singulair is a leukotriene receptor antagonist...in the same class as Accolate (zafirlukast).

They both block leukotrienes in the lungs that cause bronchoconstriction and inflammation. This can lead to fewer asthma attacks and decreased use of other asthma meds.

Practical advice for a better career, with unlimited access to CE

Pharmacy Technician's Letter Canada includes:

12 issues every year, with brief articles about new meds and hot topics
120+ CE courses, including the popular CE-in-the-Letter
Helpful, in-depth Technician Tutorials
Access to the entire archive

Subscribe Today!

Already a subscriber? Log in

Volume pricing available. Get a quote

Hear a lot more about homocysteine
Cardiology Unique timed-release verapamil for hypertension or angina.
Cardiology Whether patients can still take erythromycin before dental procedures to prevent bacterial endocarditis.
Airomir, a new salbutamol metered-dose inhaler
Serevent for chronic obstructive pulmonary disease (COPD)
New drug for asthma, Singulair (montelukast)
Venastat to relieve leg swelling due to varicose veins.
Women's Health Topical testosterone for libido
Women's Health Alesse (pronounced "A-less")
Diabetes Warning about which patients shouldn't take metformin (Glucophage)
STIs New STD treatment guidelines.
Neurology & Pain Another new drug for Parkinson's has just hit the market
Neurology & Pain New oral migraine drug called Amerge
Obesity & Weight Loss New obesity drug, Meridia (sibutramine)
Poison Prevention National Poison Prevention Week is this month.
Practice diabetics on calcium blockers might suffer more heart attacks

New drug for asthma, Singulair (montelukast)

Practical advice for a better career, with unlimited access to CE

Table of Contents